approved EB-2 (NIW)

Research Scientist

Synthetic Chemistry · Nepal · 2022-03-07

Processing Time
287 days
Decision Date
2022-03-07
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on developing new chemical reactions to shorten synthetic routes and improve molecular complexity. This work aims to reduce the overall cost of developing drug therapies to treat cancer and other diseases by advancing the production of vital new pharmaceuticals.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research advances the development of vital new drugs and reduces the economic burden of cancer.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 6 publications, a patent application, and peer review experience demonstrates his authority in the field.

3 Balance of Factors to Waive Job Offer Met

The petitioner's work is of immense value to public health and millions of people worldwide, justifying the waiver.

Why This Petition Was Approved

The case was approved based on 6 peer-reviewed journal articles (3 first-authored), 1 international patent application, and 31 citations. The petitioner demonstrated significant impact through 5 major funding sources including the NIH and NSF, as well as 5 expert recommendation letters and experience as a peer reviewer for acclaimed journals.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Scientist

Pharmaceuticals · New Zealand

WeGreened EB-2 (NIW) approved
California 467 days 2025-03-05
The petitioner proposes to design and optimize novel small-molecule therapeutics to improve cancer patient outcomes, specifically targeting difficult-to-treat cancers. Their work involves leveraging synthetic organic chemistry and catalysis to develop innovative approaches for constructing biologically active lead compounds with enhanced pharmacological profiles.

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.

Postdoctoral Researcher

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Illinois 535 days 2026-01-16
The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.

Research Assistant

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
California 426 days 2025-01-08
The petitioner proposes to continue research in pharmaceutical chemistry with a focus on drug discovery optimization and the development of advanced computational techniques. This work involves identifying new therapeutics for human diseases and creating computational methods that offer significant advantages over conventional drug discovery approaches. The intended impact is to reduce the economic and social costs of disease while improving global public health.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 287 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist